Research Findings

CB1 & CB2 Receptors in the skeletal system and nerve terminals have been shown to prevent age related bone loss and stimulate bone growth

Research


Skeletal Lipidomics

Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family

Long-chain Polyunsaturated

Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis.

Regulation of Bone Mass

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.

Peripheral Cannabinoid Receptor

Peripheral cannabinoid receptor, CB2, regulates bone mass.

Natural Products as Alternative Treatments

Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health.

Cannabinoid Receptors

Cannabinoid receptors and the regulation of bone mass.

Endocannabinoids and The Regulation

Endocannabinoids and the regulation of bone metabolism.

The Endovanilloid System

The endovanilloid/endocannabinoid system in human osteoclasts: Possible involvement in bone formation and resorption.

Endocannabinoid System

The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy.

Cannabinoids & The Skeleton

Cannabinoids and the skeleton: From marijuana to reversal of bone loss.

Cannabinoid Receptor

Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells.

Cannabinoids & Bone

Cannabinoids and bone: Friend or foe?

Receptors as Target

Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies.

Cannabidiol decreases Bone Resorption

Cannabidiol (CBD) is a cannabinoid component from Cannabis sativa that does not induce psychotomimetic effects and possess anti-inflammatory properties. 

CBDual is a portfolio company of THC Farmaceuticals, a publicly traded company as CBDG.

error: Content is protected !!